Company record
Meridian Bioscience, Inc
1 FDA warning letter since 2023 and 3 recalls in the last 12 months.
Get an email the day FDA posts anything new about Meridian Bioscience, Inc.
Warning letters
-
DevicesMeridian Bioscience, Inc
FDA warns Meridian Bioscience's Magellan Diagnostics over quality system failures and unreported problems with its blood lead test kits.
High risk
Recalls
| Reported | Class | Firm | Product and reason |
|---|---|---|---|
| Jan 14 | Class II | Meridian Bioscience Inc Device |
Revogene C. difficile, in vitro diagnostic assay intended for use with the Revogene instrument, Catalog Number 410300 The affected lots show a decline in performance over time, which may lead to false-negative results. |
| Nov 26, 2025 | Class II | Meridian Bioscience Inc Device |
Meridian Bioscience, alethia c. Difficile, Catalog Number 480050, Nucleic Acid Amplification Test Assay The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume. |
| Nov 26, 2025 | Class II | Meridian Bioscience Inc Device |
Meridian Bioscience, Group B Streptococcus, Catalog Number 480050, Nucleic Acid Amplification Test Assay The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume. |